AIM ImmunoTech Inc. Logo

AIM ImmunoTech Inc.

Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.

AIM | US

Overview

Corporate Details

ISIN(s):
US42366C3016
LEI:
Country:
United States of America
Address:
2117 SW HIGHWAY 484, 32801 OCALA

Description

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics for various diseases. The company's primary areas of focus include oncology, immune disorders, and viral diseases. Its lead drug candidate is Ampligen® (rintatolimod), a proprietary immuno-modulator with broad-spectrum activity demonstrated in pre-clinical testing. Ampligen® is being evaluated in multiple clinical studies for a range of debilitating and life-threatening conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-12 09:30
AIM Notice - 12/01/2026
English HTML 7.8 KB
2025-12-17 17:30
8-K
English ZIP 69.7 KB
2025-12-11 19:21
S-1
English ZIP 270.2 KB
2025-11-19 08:00
8-K
English ZIP 195.6 KB
2025-11-17 17:36
10-Q
English ZIP 1.5 MB
2025-11-17 07:07
NT 10-Q
English ZIP 16.1 KB
2025-10-30 18:00
424B5
English ZIP 110.1 KB
2025-10-29 18:16
8-K
English ZIP 101.6 MB
2025-10-29 17:30
DEF 14A
English ZIP 7.2 MB
2025-10-20 11:16
8-K
English ZIP 12.8 MB
2025-08-14 18:15
10-Q
English ZIP 1.3 MB
2025-07-31 18:45
8-K
English ZIP 584.3 KB
2025-07-30 08:30
424B5
English ZIP 114.7 KB
2025-07-29 02:15 English ZIP 5.2 KB
2025-07-28 11:20
8-K
English ZIP 119.6 KB

Automate Your Workflow. Get a real-time feed of all AIM ImmunoTech Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AIM ImmunoTech Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AIM ImmunoTech Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Azenta, Inc. Logo
Offers sample management, storage, and multiomics solutions for life sciences.
United States of America
AZTA
BenevolentAI Logo
Applies artificial intelligence to accelerate drug discovery and development.
United Kingdom
BAI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics and targeted therapeutics for cancer.
United States of America
BIAF
BioArctic Logo
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
Sweden
BIOA
BioInfra Co.,Ltd. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
199730
BioInfra Life Science Inc. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
266470
BioNexus Gene Lab Corp Logo
Develops gene-based diagnostics for early detection of disease susceptibility.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
France
ALBPS
BioRestorative Therapies, Inc. Logo
Develops adult stem cell therapies for degenerative disc and metabolic disorders.
United States of America
BRTX
BioSenic SA Logo
Develops therapies for autoimmune diseases, inflammation, and bone disorders.
Belgium
BIOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.